Eisai Co., Ltd.
Eisai Co., Ltd. has 1 licensing announcement in this dataset, dated 2026-07-28.
- Country / operating region
- Japan
- Ticker
- 4523.T
- Headquarters
- Tokyo, Japan
- Founded
- 1941
- Business
- Pharmaceutical research, development, manufacture, sale, import and export
- Website
- www.eisai.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| Multiple undisclosed preclinical oncology programs | 查無 | 查無 | preclinical | 2026-07-28 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2026-07-28 | CORE Biomedicine, Inc. | Multiple undisclosed preclinical oncology programs | 查無 | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| CORE Biomedicine, Inc. | Worldwide | 查無 |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無